Implementing a translational approach in the Ayurveda curriculum – Illuminating Ayurveda wisdom with scientific and technological advancements

The word “curriculum” derives from the Latin “Currere” - to run, to proceed - capturing the idea of a living course of intellectual formation rather than a static repository of facts.1 In Ayurveda, this formation has traversed a remarkable arc: from the experiential, Guru-disciple transmission of the Gurukula tradition to the formalised Ayurvedacharya degree standardised by 1970, and through successive national deliberations - the Chopra Committee (1946) and the Mudaliar Committee (1962) - on how best to situate classical knowledge within a rapidly modernising healthcare landscape.2 Today, with the National Commission for Indian System of Medicine (NCISM) initiating a substantive curriculum revision anchored in translational science, that question has acquired renewed urgency and, at last, a productive answer. Translational research - the systematic conversion of bench discoveries into bedside interventions and community health outcomes - forms the conceptual spine of this revision.3 As the European Society for Translational Medicine defines it, the discipline rests on three pillars: bench-side investigation, bedside clinical application, and community impact.4 For Ayurveda, adopting this framework does not mean subordinating classical principles to modern science. It means deploying the precision instruments of contemporary research to reveal, articulate, and substantiate what Ayurvedic scholarship has long asserted. The aspiration is not to validate Ayurveda by external standards alone, but to demonstrate that its foundational doctrines - developed through centuries of systematic observation, reasoning, and clinical refinement - possess a biological reality that modern tools are only now becoming sophisticated enough to capture. Consider the core principles at stake. The concept of Dosha describes dynamic functional forces governing physiology; Agni governs transformation and metabolism at every level of biological organisation; Dhatu describes hierarchically organised tissue formation; Prakriti defines the individual constitutional substrate that determines disease susceptibility and therapeutic response; and Rasayana encompasses interventions that restore, rejuvenate, and sustain biological vitality. These are not metaphorical constructs. They are clinically grounded functional categories that await mechanistic elucidation. The limitation has never been in the principles themselves but in the inadequacy of available experimental models to probe them. Conventional two-dimensional cell cultures, which strip away the architectural complexity of living tissue, and animal models, whose cross-species translational fidelity is widely questioned, have consistently fallen short of this task. A new generation of advanced in-vitro platforms now provides the resolution that was previously unavailable. Organ-on-a-Chip (OoC) devices - microfluidic platforms sustaining living human cells under physiological fluid flow, mechanical forces, and cell–cell signalling — and three-dimensional (3D) bioprinted tissue constructs together constitute a transformative toolkit for Ayurvedic research.5,6 Their regulatory recognition under the US FDA Modernization Acts 2.0 (2022)7 and 3.0 (2024)8 as admissible preclinical evidence signals a global shift in scientific standards that Indian regulatory bodies should formally align with. More importantly for our purposes, each platform maps directly onto a classical Ayurvedic principle awaiting scientific articulation. Gut-liver axis chips, which dynamically replicate intestinal absorption and first-pass hepatic metabolism, offer the first truly human-relevant experimental model of Agni in its metabolic-transformative dimension.9 Gut-on-chip studies have already characterised curcumin (Haridra) intestinal permeability in real time, and linked intestine-liver platforms have provided a mechanistic biochemical account of piperine-mediated CYP3A4 modulation, illuminating the classical principle of Yogavahi (carrier-mediated potentiation of drug action) with molecular precision.10 Liver-on-chip11 and kidney-on-chip12 models, sustaining long-term culture under physiological shear stress, generate human-relevant hepatotoxicity and nephrotoxicity data that can at last resolve the protracted safety debate surrounding Bhasmas and Rasa Aushadhis, establishing, on credible scientific grounds, what classical Ayurvedic processing and detoxification methodologies have always claimed: that properly prepared metallic formulations are therapeutically effective and safe within defined parameters. Patient-derived iPSC (Induced pluripotent stem cell)-based organ chips,13 by enabling constitutional biology to be modelled at the cellular level, offer the most rigorous platform yet for validating Prakriti-based differential therapeutic responses, translating Ayurveda’s foundational insight into personalised medicine into experimentally falsifiable science. Three-dimensional bioprinted skin constructs provide reproducible models for the pharmacokinetic evaluation of topical Tailas and Lepas, while bioprinted cartilage and bone organoids enable a mechanistic study of the anti-inflammatory and tissue-regenerative properties attributed to Shallaki and Guduchi in classical Rasayana literature. In a further convergence, Ayurvedic biomaterials — honey, ghee, and plant-derived polysaccharides — whose biological properties are themselves described in classical texts, possess the biocompatibility characteristics required for novel bioink formulation, suggesting that Ayurveda may contribute materially, and not merely conceptually, to the future of tissue engineering. Embedding conceptual and applied literacy in these platforms into the revised Ayurveda curriculum is, therefore, a strategic imperative. Ayurveda scholars who understand the logic of microfluidic tissue modelling,14 organoid biology, and organ-chip pharmacology will be equipped to lead research that speaks fluently to the global biomedical community, without relinquishing the epistemological foundations of their tradition. Institutional collaborations between CSIR, ICMR, ICAR, NIPER, IIT, and the Ministry of Ayush-linked research bodies with bioengineering and biotechnology departments represent the natural next step towards advancement in evidence-based evaluation and understanding of Ayurveda fundamental principles.15,16 In conclusion, the integration of advanced in vitro platforms into Ayurvedic translational research must be understood in its correct epistemic orientation: modern tools are not the measure of Ayurveda’s worth, but instruments in its service. The fundamental principles of Ayurveda, its understanding of constitution, metabolism, tissue formation, and rejuvenation; remain the intellectual anchor. What organ-on-chip systems, 3D bioprinted organoids, and microphysiological platforms offer is a scientific language precise enough, and a biological resolution high enough, to demonstrate what classical Ayurvedic scholars perceived through centuries of disciplined clinical observation. The revised curriculum, grounded in this orientation, does not diminish Ayurveda by subjecting it to scientific scrutiny; it elevates it by providing the tools to make its wisdom legible, reproducible, and universally communicable. The current special issue of the Journal of Research in Ayurvedic Sciences, exploring Ayurveda principles through the lens of contemporary applied technologies, is a timely and significant step in precisely this direction. Financial support and sponsorship Nil. Conflicts of interest There are no conflicts of interest.